Non-genetic determinants of malignant clonal fitness at single-cell resolution.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 2022
Historique:
received: 09 11 2020
accepted: 30 10 2021
pubmed: 10 12 2021
medline: 30 3 2022
entrez: 9 12 2021
Statut: ppublish

Résumé

All cancers emerge after a period of clonal selection and subsequent clonal expansion. Although the evolutionary principles imparted by genetic intratumour heterogeneity are becoming increasingly clear

Identifiants

pubmed: 34880496
doi: 10.1038/s41586-021-04206-7
pii: 10.1038/s41586-021-04206-7
doi:

Substances chimiques

Secretory Leukocyte Peptidase Inhibitor 0
Slpi protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-131

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Turajlic, S., Sottoriva, A., Graham, T. & Swanton, C. Resolving genetic heterogeneity in cancer. Nat. Rev. Genet. 20, 404–416 (2019).
pubmed: 30918367
Marine, J. C., Dawson, S. J. & Dawson, M. A. Non-genetic mechanisms of therapeutic resistance in cancer. Nat. Rev. Cancer 20, 743–756 (2020).
pubmed: 33033407
Rodriguez-Fraticelli, A. E. et al. Single-cell lineage tracing unveils a role for TCF15 in haematopoiesis. Nature 583, 585–589 (2020).
pubmed: 32669716 pmcid: 7579674
Lin, D. S. et al. DiSNE movie visualization and assessment of clonal kinetics reveal multiple trajectories of dendritic cell development. Cell Rep. 22, 2557–2566 (2018).
pubmed: 29514085
Greaves, M. When one mutation is all it takes. Cancer Cell 27, 433–434 (2015).
pubmed: 25873168
Visvader, J. E. Cells of origin in cancer. Nature 469, 314–322 (2011).
pubmed: 21248838
Krivtsov, A. V. et al. Cell of origin determines clinically relevant subtypes of MLL-rearranged AML. Leukemia 27, 852–860 (2013).
pubmed: 23235717
Pendleton, M., Lindsey, R. H. Jr, Felix, C. A., Grimwade, D. & Osheroff, N. Topoisomerase II and leukemia. Ann. N. Y. Acad. Sci. 1310, 98–110 (2014).
pubmed: 24495080 pmcid: 3961513
Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10, 257–268 (2006).
pubmed: 17045204
Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818–822 (2006).
pubmed: 16862118
Dahlin, J. S. et al. A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice. Blood 131, e1–e11 (2018).
pubmed: 29588278 pmcid: 5969381
Matsuo, H. et al. Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML. Blood Adv. 4, 4623–4631 (2020).
pubmed: 32991719 pmcid: 7556160
The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059–2074 (2013).
pmcid: 3767041
Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431–435 (2017).
pubmed: 28607484 pmcid: 5542814
Raj, A. & van Oudenaarden, A. Nature, nurture, or chance: stochastic gene expression and its consequences. Cell 135, 216–226 (2008).
pubmed: 18957198 pmcid: 3118044
Larsson, A. J. M. et al. Genomic encoding of transcriptional burst kinetics. Nature 565, 251–254 (2019).
pubmed: 30602787 pmcid: 7610481
MacPherson, L. et al. HBO1 is required for the maintenance of leukaemia stem cells. Nature 577, 266–270 (2020).
pubmed: 31827282
Coombs, C. C., Tavakkoli, M. & Tallman, M. S. Acute promyelocytic leukemia: where did we start, where are we now, and the future. Blood Cancer J. 5, e304 (2015).
pubmed: 25885425 pmcid: 4450325
Jones, C. L., Inguva, A. & Jordan, C. T. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell 28, 378–393 (2021).
pubmed: 33667359 pmcid: 7951949
Zuber, J. et al. Mouse models of human AML accurately predict chemotherapy response. Genes Dev. 23, 877–889 (2009).
pubmed: 19339691 pmcid: 2666344
Duy, C. et al. Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence. Cancer Discov. 11, 1542–1561 (2021).
pubmed: 33500244 pmcid: 8178167
Bell, C. C. et al. Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia. Nat. Commun. 10, 2723 (2019).
pubmed: 31222014 pmcid: 6586637
Rambow, F. et al. Toward minimal residual disease-directed therapy in melanoma. Cell 174, 843–855 (2018).
pubmed: 30017245
Fong, C. Y. et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature 525, 538–542 (2015).
pubmed: 26367796 pmcid: 6069604
Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104–108 (2017).
pubmed: 28658204
Zorita, E., Cusco, P. & Filion, G. J. Starcode: sequence clustering based on all-pairs search. Bioinformatics 31, 1913–1919 (2015).
pubmed: 25638815 pmcid: 4765884
Silver, D. P. & Livingston, D. M. Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol. Cell 8, 233–243 (2001).
pubmed: 11511376
Kebschull, J. M. & Zador, A. M. Cellular barcoding: lineage tracing, screening and beyond. Nat. Methods 15, 871–879 (2018).
pubmed: 30377352
Naik, S. H., Schumacher, T. N. & Perie, L. Cellular barcoding: a technical appraisal. Exp. Hematol. 42, 598–608 (2014).
pubmed: 24996012
Ye, M. et al. Hematopoietic differentiation is required for initiation of acute myeloid leukemia. Cell Stem Cell 17, 611–623 (2015).
pubmed: 26412561 pmcid: 4636971
Naik, S. H. et al. Diverse and heritable lineage imprinting of early haematopoietic progenitors. Nature 496, 229–232 (2013).
pubmed: 23552896
Langmead, B. Aligning short sequencing reads with Bowtie. Curr. Protoc. Bioinform. 32, 11.7.1–11.7.14 (2010).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002
Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022–2032 (2014).
pubmed: 25236618 pmcid: 4248318
McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).
pubmed: 27268795 pmcid: 4893825
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
doi: 10.1016/j.cell.2019.05.031 pubmed: 31178118 pmcid: 6687398
Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
pubmed: 29608179 pmcid: 6700744
Stoeckius, M. et al. Cell hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol. 19, 224 (2018).
pubmed: 30567574 pmcid: 6300015
Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).
pubmed: 31870423 pmcid: 6927181
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38–44 (2018).
Zappia, L. & Oshlack, A. Clustering trees: a visualization for evaluating clusterings at multiple resolutions. Gigascience 7, giy083 (2018).
pmcid: 6057528
Finak, G. et al. MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data. Genome Biol. 16, 278, (2015).
pubmed: 26653891 pmcid: 4676162
Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92–94, (2017).
pubmed: 29059683 pmcid: 5798588
Marjanovic, N. D. et al. emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell 38, 229–246 (2020).
pubmed: 32707077 pmcid: 7745838
Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293–1308 (2018).
pubmed: 29961579 pmcid: 6348010

Auteurs

Katie A Fennell (KA)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Dane Vassiliadis (D)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Enid Y N Lam (EYN)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Luciano G Martelotto (LG)

The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia.

Jesse J Balic (JJ)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Sebastian Hollizeck (S)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Tom S Weber (TS)

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
The Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.

Timothy Semple (T)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia.

Qing Wang (Q)

Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.

Denise C Miles (DC)

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
The Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.

Laura MacPherson (L)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Yih-Chih Chan (YC)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Andrew A Guirguis (AA)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Lev M Kats (LM)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Emily S Wong (ES)

Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.
School of Biotechnology and Biomolecular Sciences, UNSW, Sydney, New South Wales, Australia.

Sarah-Jane Dawson (SJ)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia.

Shalin H Naik (SH)

The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
The Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.

Mark A Dawson (MA)

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Mark.Dawson@petermac.org.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. Mark.Dawson@petermac.org.
The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia. Mark.Dawson@petermac.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH